Comparing the current results to its competitors, Avita Medical Inc reported Revenue increase in the 2 quarter 2026 by 17.83 % year on year. The sales growth was above Avita Medical Inc 's competitors' average revenue growth of 5.57 %, achieved in the same quarter.
Avita Medical Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 102.25 %
Overall company sales advanced by 17.83 % Avita Medical Inc outperformed its competitors in this segment and improved market share, to approx. 0.16 %. << More on RCEL Market Share.
*Market share is calculated based on total revenue.
October 28, 2025
In a significant step towards enhancing patient care for burn injuries, AVITA Medical has received positive endorsement from the Medical Services Advisory Committee (MSAC) in Australia for its groundbreaking RECELL system. This innovative technology offers promising treatment solutions by harnessing the body s own healing capabilities, effectively transforming the landscape of burn management. RECELL s Endorsement in Australia The MSAC’s backing underscores the RECELL system s multifaceted benefits - its safety profile, the potential for expedited healing, donor site sparing, and the ability to significantly reduce the duration of hospital stays for patients suffering from burns. RECELL utilizes a unique p...
December 19, 2024
In a significant turn of events for AVITA Medical (NASDAQ: AVTA), the company has recently announced the FDA’s 510(k) clearance for its innovative product, Cohealyx. This regulatory approval expands AVITA s addressable market, suggesting new growth opportunities that could bolster its standing in the competitive healthcare landscape. However, this achievement arrives on the heels of some concerning financial metrics that necessitate a closer look.The third quarter of 2024 has shown a notable increase in AVITA s current liabilities, with the quick ratio dipping to 2.59. This marked decline represents a new company low, raising concerns among investors and industry analysts alike. To put this figure into con...
July 31, 2024
In a significant move aimed at enhancing wound care solutions, AVITA Medical has announced the expansion of its product portfolio through an exclusive development and distribution agreement with Regenity Biosciences. This partnership will enable AVITA Medical to introduce a new collagen dermal matrix, a novel technology designed to optimize healing for patients with a variety of wound types. What is the Collagen Dermal Matrix The collagen dermal matrix is a sophisticated medical device intended to facilitate and accelerate the body s natural healing processes. By providing structural support and promoting cellular regeneration, it targets both acute and chronic wounds, potentially leading to improved patient...
Anika Therapeutics Inc is a medical technology company that focuses on developing and commercializing therapeutic products to treat tissue-related disorders. Their business model revolves around conducting extensive research and development to create innovative therapies, partnering with healthcare professionals and distributors to bring their products to market, and generating revenue through the sale of these products worldwide. They also collaborate with other companies and academic institutions to enhance their product portfolio and expand their reach in the healthcare industry.
Strata Skin Sciences Inc's business model revolves around developing and marketing innovative medical devices and products for dermatology and aesthetic procedures.
Tela Bio Inc is a company that operates on a business model centered around developing and commercializing novel medical products for soft tissue repair and reconstruction.
Venus Concept Inc's business model focuses on offering innovative and effective medical aesthetic devices and technology solutions to healthcare professionals.
Vycor Medical Inc has a business model focused on developing and commercializing innovative medical devices and technologies in the healthcare industry.
Sources:
Avita Medical Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Avita Medical Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
